Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase/Visfatin Enzymatic Activity Identifies a New Inflammatory Pathway Linked to NAD

Nathalie Busso, Mahir Karababa, Massimo Nobile et al. · 2008

Read Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase/Visfatin Enzymatic Activity Identifies a New Inflammatory Pathway Linked to NAD by Nathalie Busso, Mahir Karababa, Massimo Nobile et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0002267.txt.

Description

Nathalie Busso, Mahir Karababa, Massimo Nobile, and co-authors blocked an enzyme tied to inflammation and found a new pathway, in a 2008 PLOS ONE paper. The enzyme NAMPT, also called visfatin, is the rate-limiting step in the cell's salvage route for making NAD, a molecule vital for energy use. Its levels rise during inflammation, and it had been flagged as a marker in acute lung injury.

By inhibiting NAMPT with a drug, the team showed its activity drives an inflammatory pathway linked to NAD levels. The link suggests that dialing down this one enzyme could cool inflammation in diseases where NAD balance runs off track.

Catalog record

CREATORNathalie Busso, Mahir Karababa, Massimo Nobile et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE47 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0002267

Browse the full library · About the Tower of Babel